Elsevier

Brain Research

Volume 289, Issues 1–2, 19 December 1983, Pages 391-394
Brain Research

Relationship of duration of analgesia to opioid pharmacokinetic variables

https://doi.org/10.1016/0006-8993(83)90049-5Get rights and content

Abstract

That physiological effects are directly related to concentration at the site of action has been validated for only a few classes of drugs. For opiates, a direct correlation is known to exist between concentration and magnitude of analgesia, but has not been shown for duration of analgesia. These experiments in rats, using opiates whose elimination half-lives differ by a factor of 2 1/2, in a range of doses that produce 10–90% of maximal analgesic effect, show that duration is not dependent on dose or rate of elimination of opiate analgesics. The data suggest that analgesic duration is not determined by the pharmacokinetics of opiates at the receptors where these drugs act to elicit analgesia.

References (24)

  • Dahlstro¨mB.E. et al.

    Pharmacokinetics of morphine in plasma and discrete areas of the rat brain

    J. Pharmacokinet. Biopharm.

    (1975)
  • ercoliN. et al.

    Studies on analgesics. I. The time-action curves of morphine, codeine, dilaudid and demerol by various methods of administration

    J. Pharmacol. exp. Ther.

    (1945)
  • Cited by (7)

    • Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies

      2021, Drug and Alcohol Dependence
      Citation Excerpt :

      In both studies that demonstrated analgesic efficacy, the opioid was administered at trough methadone or buprenorphine levels (Hay et al., 2008; Huhn et al., 2019); in others, however, opioid administration at trough OAT levels did not produce analgesia (Athanasos et al., 2019; Athanasos et al., 2006; Compton et al., 2000; Doverty et al., 2001). Notably, the analgesic effects of methadone and buprenorphine may be both time- and dose-dependent, and are generally shorter in duration than their withdrawal suppression effects, which may specifically affect experimental pain assessments conducted at peak OAT levels (Levine et al., 1983). This variation in analgesic effects is in part due to individual differences in elimination half-lives, which can result in distinct rates of accumulation, with potential impact on analgesia (Mercadante et al., 1996).

    • Do food and dose timing affect the efficacy of sildenafil? A randomized placebo-controlled study

      2007, Journal of Sexual Medicine
      Citation Excerpt :

      All of these data suggest that the duration of action of sildenafil substantially exceeds its terminal elimination half‐life of approximately 4 hours [7]. This finding is not surprising, as other drug classes have durations of action that substantially exceed half‐lives [25–28]. The long duration of action of sildenafil may be related to its extensive distribution into tissues [18].

    View all citing articles on Scopus

    This research was supported by NIH Grants AM 32634, DE 05369, DA 01949 and a KROC foundation grant.

    View full text